Degludec

DRUG7 trials

Sponsors

Internal Medicine 1, Shimane University Faculty of Medicine, Hennepin Healthcare Research Institute, Emory University, Ain Shams University, University of Split, School of Medicine

Conditions

Diabetes MellitusDiabetes Mellitus, Type 2Type 1 Diabetes Mellitus With HypoglycemiaType 2 DiabetesType 2 diabetes mellitustype1diabetes

Phase 2

A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin

RecruitingNCT07215312

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2025-10-13End: 2026-12-01Target: 100Updated: 2026-03-02

Phase 4

Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes

CompletedNCT03336528

Emory UniversityType 2 Diabetes

Start: 2018-01-02End: 2021-03-01Updated: 2022-03-31

Intermediate and Long Acting Insulin Young Children Type 1 Diabetes.

Ain Shams Universitytype1diabetes, Type 1 Diabetes Mellitus With Hypoglycemia

Start: 2019-02-21End: 2021-03-10Target: 60Updated: 2021-02-16

Insulin Glargine U300 vs Insulin Degludec U100 in Impact on the Glycaemic and Cardiovascular Factors

CompletedNCT04692415

University of Split, School of MedicineDiabetes Mellitus, Type 2

Start: 2018-12-15End: 2019-06-27Updated: 2020-12-31

Unknown Phase

The efficacy of insulin degludec on plasma glucose control in diabetes mellitus

Active, not recruitingJPRN-UMIN000011333

Internal Medicine 1, Shimane University Faculty of MedicineType 2 diabetes mellitus

Start: 2013-08-01Target: 40Updated: 2025-07-18

Insulin Degludec for the Management of Patient With Recurrent Diabetic Ketoacidosis

TerminatedNCT03001323

Hennepin Healthcare Research InstituteDiabetes Mellitus

Start: 2017-01-31End: 2020-09-25Updated: 2021-05-17

Degludec Glargine U300 Hospital Study

CompletedNCT05036876

Medanta, The Medicity, IndiaType 2 Diabetes

Start: 2021-10-10End: 2022-03-01Updated: 2024-12-09

Related Papers

Comparison of the Impact of Insulin Degludec U100 and Insulin Glargine U300 on Glycemic Variability and Oxidative Stress in Insulin-Naive Patients With Type 2 Diabetes Mellitus: Pilot Study for a Randomized Trial

JMIR Formative Research2022-07-081 citations

The differences between insulin glargine U300 and insulin degludec U100 in impact on the glycaemic variability, arterial stiffness and the lipid profiles in insulin naïve patients suffering from type two diabetes mellitus - outcomes from cross-over open-label randomized trial.

2021-04-291 citations